These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2892361)
21. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA). Talkington DF; Brown BG; Tharpe JA; Koenig A; Russell H Microb Pathog; 1996 Jul; 21(1):17-22. PubMed ID: 8827703 [TBL] [Abstract][Full Text] [Related]
22. The immune response of the mammary gland and its significance for the neonate. Hanson LA; Ahlstedt S; Andersson B; Cruz JR; Dahlgren U; Fällström SP; Porras O; Svanborg Edén C; Söderström T; Wettergren B Ann Allergy; 1984 Dec; 53(6 Pt 2):576-82. PubMed ID: 6391286 [TBL] [Abstract][Full Text] [Related]
23. The secretory IgA system and mucosal defence. Hanson LA; Andersson B; Carlsson B; Cruz JR; Dahlgren U; Baltzer IM; Edén CS Scand J Infect Dis Suppl; 1980; Suppl 24():13-21. PubMed ID: 7010551 [No Abstract] [Full Text] [Related]
24. The antibody response in infants after oral administration of inactivated and living E. coli vaccines and their protective effect against nosocomial infections. Lodinová-Zádníková R; Tlaskalová H; Korych B; Bartáková Z Adv Exp Med Biol; 1995; 371B():1431-8. PubMed ID: 7502832 [No Abstract] [Full Text] [Related]
25. A combination of Flt3 ligand cDNA and CpG oligodeoxynucleotide as nasal adjuvant elicits protective secretory-IgA immunity to Streptococcus pneumoniae in aged mice. Fukuyama Y; King JD; Kataoka K; Kobayashi R; Gilbert RS; Hollingshead SK; Briles DE; Fujihashi K J Immunol; 2011 Feb; 186(4):2454-61. PubMed ID: 21242514 [TBL] [Abstract][Full Text] [Related]
27. Secretory immunoglobulin A obtained from pooled human colostrum and milk for oral passive immunization. Carbonare CB; Carbonare SB; Carneiro-Sampaio MM Pediatr Allergy Immunol; 2005 Nov; 16(7):574-81. PubMed ID: 16238582 [TBL] [Abstract][Full Text] [Related]
29. Mucosal and systemic immunization with pneumococcal polysaccharide type 3, 4 and 14 in the rat. van den Dobbelsteen GP; Brunekreef K; Sminia T; van Rees EP Adv Exp Med Biol; 1995; 371B():1605-10. PubMed ID: 7502866 [No Abstract] [Full Text] [Related]
30. [Prospects for the development of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (3)]. Cravioto A Bol Med Hosp Infant Mex; 1984 May; 41(5):253-61. PubMed ID: 6147148 [No Abstract] [Full Text] [Related]
31. Antibody response of children with enteropathogenic Escherichia coli infection to the bundle-forming pilus and locus of enterocyte effacement-encoded virulence determinants. Martinez MB; Taddei CR; Ruiz-Tagle A; Trabulsi LR; Girón JA J Infect Dis; 1999 Jan; 179(1):269-74. PubMed ID: 9841853 [TBL] [Abstract][Full Text] [Related]
33. Effect of microwave radiation, pasteurization and lyophilization on the ability of human milk to inhibit Escherichia coli adherence to HEp-2 cells. Carbonare SB; Palmeira P; Silva ML; Carneiro-Sampaio MM J Diarrhoeal Dis Res; 1996 Jun; 14(2):90-4. PubMed ID: 8870401 [TBL] [Abstract][Full Text] [Related]
34. Observation on receptor specific proteins I. Haemagglutination and haemagglutination-inhibition reactions of two mannose-resistant strains of Escherichia coli. Balding P; Gold ER Z Immunitatsforsch Exp Klin Immunol; 1973 Sep; 146(1):36-44. PubMed ID: 4157050 [No Abstract] [Full Text] [Related]
35. Mucosal immunity of the mammary gland and immunology of mother/newborn interrelation. Chernishov VP; Slukvin II Arch Immunol Ther Exp (Warsz); 1990; 38(1-2):145-64. PubMed ID: 2288471 [TBL] [Abstract][Full Text] [Related]
36. Pneumococcal otitis media vaccine trials. Klein JO Pediatr Infect Dis J; 1989 Jan; 8(1 Suppl):S82-3. PubMed ID: 2648301 [No Abstract] [Full Text] [Related]
37. Toll-like receptors recognize uropathogenic Escherichia coli and trigger inflammation in the urinary tract. Anders HJ; Patole PS Nephrol Dial Transplant; 2005 Aug; 20(8):1529-32. PubMed ID: 15941847 [No Abstract] [Full Text] [Related]
38. Differences in inhibition of the growth of commensal and enteropathogenic strains of Escherichia coli by lactotransferrin and secretory immunoglobulin A isolated from human milk. Stephens S; Dolby JM; Montreuil J; Spik G Immunology; 1980 Nov; 41(3):597-603. PubMed ID: 7007213 [TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics of a novel 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine candidate (PHiD-CV). Introduction. Dagan R; Frasch C Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S63-5. PubMed ID: 19325448 [No Abstract] [Full Text] [Related]
40. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant. Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]